Research and Markets (http://www.researchandmarkets.com/research/r8jntw/ischemic) has announced the addition of the "Ischemic Stroke-Pipeline Insights, 2015" subscription to their offering.
This Ischemic Stroke-Pipeline Insights report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Ischemic Stroke.
This report provides information on the therapeutic development based on the Ischemic Stroke dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information.
The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.
Key Topics Covered:
- Ischemic Stroke Overview
- Ischemic Stroke Pipeline Therapeutics
- Ischemic Stroke Therapeutics under Development by Companies
- Ischemic Stroke Late Stage Products (Filed and Phase III)
- Comparative Analysis
- Ischemic Stroke Mid Clinical Stage Products (Phase II)
- Comparative Analysis
- Ischemic Stroke Early Clinical Stage Products (Phase I and IND Filed)
- Comparative Analysis
- Ischemic Stroke Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Ischemic Stroke - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Ischemic Stroke - Discontinued Products
- Ischemic Stroke - Dormant Products
- Companies Involved in Therapeutics Development for Ischemic Stroke
- Appendix
For more information visit http://www.researchandmarkets.com/research/r8jntw/ischemic